Received Oct 30, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (PRIORIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Priorix was administered post expiration; This non-serious case was reported by a nurse via other manufacturer and described the occurrence of expired vaccine used in a patient who received MMR (Priorix) (expiry date 01-SEP-2025) for prophylaxis. On an unknown date, the patient received Priorix. On an unknown date, an unknown time after receiving Priorix, the patient experienced expired vaccine used (Verbatim: Priorix was administered post expiration). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 15-OCT-2025 Nurse calling to report an adverse event for Priorix and realized she meant to call company. The reporter stated that Priorix was administered post expiration. Confirmed no Merck product was involved. No other information was provided. No additional adverse event or no product quality complaint reported was unspecified. The batch number was not provided and a request for this information has been made.